Health Care Technology
Company Overview of MedAvante, Inc.
MedAvante, Inc. provides technology-enabled signal detection solutions in clinical trials of treatments for central nervous system disorders worldwide. Its solutions include Virgil Investigative Study Platform for site-based assessments; and MedAvante Central Ratings for live assessments by remote central clinicians. The company also provides scientific risk reduction services, such as rater qualification and training; central review, a monitoring service in which calibrated clinicians review selected assessments that were administered by site raters; and remote ratings, a customized solution that offers sponsors protection against bias and variability. MedAvante, Inc. was formerly known as ...
100 American Metro Boulevard
Hamilton, NJ 08619
Founded in 2002
Key Executives for MedAvante, Inc.
Senior Vice President of Global Operations and Information Technology
Senior Vice President of Global Science
Compensation as of Fiscal Year 2017.
MedAvante, Inc. Key Developments
WIRB-Copernicus Group Names Jeffrey Litwin as the CEO of the Combined Organization
May 9 17
WIRB-Copernicus Group announced that it has acquired MedAvante and ProPhase and has named Dr. Jeffrey Litwin as the CEO of the combined organization.
MedAvante, Inc. Appoints Michael T. Ropacki as Vice President, Research and Development
Feb 22 17
MedAvante, Inc. announced that Michael T. Ropacki, PhD, has been appointed Vice President, Research and Development to lead the company's continued expansion of clinical science and signal detection capabilities Dr. Ropacki was previously Director, Clinical Research Neuroscience, Research and Development, for Janssen Research & Development (Johnson & Johnson) where he was responsible for leading the Cognitive Health in Aging Registry: Investigational, Observational and Trial studies in dementia research – Prospective Readiness Cohort (CHARIOT-PRO) program, and he was also responsible for the development and execution of other clinical programs within the neuroscience therapeutic area.
Ian C. Neilson Joins Medavante, Inc. as Senior Vice President, Global Information Technology
Feb 8 17
MedAvante, Inc. announced that Ian C. Neilson has accepted the position of Senior Vice President, Global Information Technology to lead the company's rapidly growing IT operations supporting clinical science and signal detection capabilities. Neilson was a key senior IT executive for more than 19 years at Covance, now a division of LabCorp Holdings, serving most recently as Vice President, Technology and Innovation within the Clinical Development Services division. At Covance, Neilson was a member of the Clinical Development executive leadership team, developing the IT roadmap for long range strategic plans, and he oversaw a team of 100 IT professionals responsible for successfully delivering a multi-year, multi-million dollar process and technology transformation program. Neilson previously led IT Architecture and Compliance for Covance with responsibility for establishing and implementing IT standards, security, and quality and compliance processes across the company.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 9, 2017